TOG Review (RCOG Journal)
MRCOG Part 2
Antenatal Care
The management of chronic pain in pregnancy
Key Statistics
- >3 months — Defines chronic pain
- up to 28% — Pregnant women with pre-existing chronic pain
- 55–94% — Neonatal abstinence syndrome after antenatal opioids
Don't-miss facts
-
NSAIDs only before 28 weeks, shortest course — late use risks oligohydramnios (5×) and ductus arteriosus constriction (0.5%). Analgesic aspirin >300 mg/day in late pregnancy not advised
-
NAS in 55–94% of opioid-exposed newborns — involve neonatology early; NICE prefers replacement over detoxification; breastfeeding reduces need for withdrawal treatment
-
Codeine avoided in breastfeeding (CYP2D6 ultra-rapid metabolisers) — use dihydrocodeine. Ibuprofen/diclofenac are the postnatal NSAIDs of choice
-
Serotonergic drugs → PPH RR 1.32 (SNRI 1.79); ~34% vs 26% background — active management of the third stage; no excess risk if stopped ≥1 month before birth
-
Late SSRI: neonatal adaptation syndrome ~30% (background 10%); persistent pulmonary hypertension of the newborn ~2/1000 (background 3/1000)
-
Valproate = major teratogen; carbamazepine → dose-dependent neural tube defects; lamotrigine/levetiracetam = background 2–3%. Folic acid for all + ultrasound screening essential
-
Headache in pregnancy: exclude pre-eclampsia and cerebral venous thrombosis. Sumatriptan safe; propranolol preferred prophylaxis; no opioids for migraine/tension/cluster headache
-
Sacral nerve stimulators must not be placed or used in pregnancy; invasive neuromodulation not recommended — contact the implanting service early (spinal anaesthesia for caesarean may still be possible)
Framework
Chronic pain >3 months; up to 28% of pregnant women have a pre-existing condition; WHO ladder does not apply Classify: primary vs secondary (ICD-11) and nociceptive / neuropathic / nociplastic No pregnancy-specific chronic pain guideline; NICE NG193 omits pregnancy. Non-specialists should not initiate treatment — refer to a specialist/ad hoc MDT (maternal medicine, pain physician, neonatologist, physiotherapist, psychologist) Try non-pharmacological first; anticipate higher peripartum analgesic requirements — early anaesthetic input
Drugs at a glance
Paracetamol — safe, pregnancy & breastfeeding Sumatriptan — safe
Amitriptyline — 1st choice neuropathic pain in pregnancy NSAIDs — only <28 weeks, short course
Gabapentinoids — specialist, neonatal withdrawal Sodium valproate — major teratogen Codeine — not in breastfeeding
Intravesical dimethyl sulfoxide — teratogenic (animal)
Guideline map
NICE NG193 chronic primary pain · NG59 low back pain · CG173 neuropathic pain · CG150 headaches RCOG GTG 70 bladder pain syndrome · GTG 41 chronic pelvic pain · SIP 59 antenatal/postnatal analgesia RCP fibromyalgia (2022) and CRPS (2018) · resources: UKTIS, BUMPS, LactMed, BPS PMP directory NICE recommends CBT/ACT, exercise, acupuncture; PMPs endorsed by FPM/BPS but not by NICE; TENS not recommended for chronic pain
Abbreviation Key
- ACT — acceptance and commitment therapy
- ICD-11 — International Classification of Diseases, 11th revision
- ADHD — attention deficit hyperactivity disorder
- LactMed — Drugs and Lactation Database
- AED — antiepileptic drug
- MHRA — Medicines and Healthcare products Regulatory Agency
- aOR / aRR — adjusted odds ratio / adjusted relative risk
- NAS — neonatal abstinence syndrome
- BPS — British Pain Society
- NICE — National Institute for Health and Care Excellence
- BUMPS — Best Use of Medicines in Pregnancy
- NSAID — non-steroidal anti-inflammatory drug
- CBT — cognitive behavioural therapy
- OR / RR — odds ratio / relative risk
- CLBP — chronic low back pain
- PMP — pain management programme
- COX — cyclooxygenase
- PPH — postpartum haemorrhage
- CRPS — complex regional pain syndrome
- SNRI — serotonin–noradrenaline reuptake inhibitor
- CYP2D6 — cytochrome P450 2D6 enzyme
- SSRI — selective serotonin reuptake inhibitor
- FPM — Faculty of Pain Medicine
- TENS — transcutaneous electrical nerve stimulation
- HR — hazard ratio
- UKTIS — UK Teratology Information Service
- IASP — International Association for the Study of Pain
- WHO — World Health Organization
Source: Hutchinson L, Petrosellini C, McGuckin D et al. The management of chronic pain in pregnancy. The Obstetrician & Gynaecologist 2026;28:16–29. doi:10.1111/tog.70025
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).